LYME AB Late Disease (>30 days of signs or symptoms), with Reflex
Test Mnemonic
LMLATE
CPT Codes
- 86618 - QTY (1)
LOINC ®
34148-7
Aliases
- Borrelia burgdorferi Antibodies
Performing Laboratory
Cleveland Clinic Laboratories
Specimen Requirements
| Volume | Type | Container | Collect Temperature | Transport Temperature | Special Instructions |
|---|---|---|---|---|---|
| 0.5 mL | Serum | SST (Gold) | Refrigerated |
Minimum Specimen Requirements
| Volume | Type | Container | Collect Temperature | Transport Temperature | Special Instructions |
|---|---|---|---|---|---|
| 0.4 mL |
Stability
| Environmental Condition | Description |
|---|---|
| Ambient | 48 hours |
| Refrigerated | 14 days |
| Frozen | 15 days at -20 or below (Avoid multiple freeze/thaw cycles) |
Days Performed
Mon - Fri
Turnaround Time
1 - 4 days
Methodology
| Name | Description |
|---|---|
| Chemiluminescence Immunoassay (CLIA) |
Reference Range
| Lyme Antibodies, IgG, IgM | |||||
|---|---|---|---|---|---|
| Sex | Age From | Age To | Type | Range | Range Unit |
| Normal | Negative |
Clinical Info
Qualitative test for the presence of IgG and IgM antibodies to Borrelia burgdorferi, the causative agent of Lyme disease. Positive or equivocal results will automatically reflex to an IgG and IgM Western Blot for confirmation, and will be billed accordingly. Recent infection with B. burgdorferi sensu lato cannot be excluded if the specimen is collected within four weeks after the onset of signs and symptoms or within six weeks after a known tick exposure. Clinical and epidemiological correlation is required.
Clinical Limitation
Grossly hemolyzed, icteric or lipemic samples as well as samples containing particulate matter or exhibiting obvious microbial contamination should not be tested. The results are not by themselves diagnostic and should be considered in association with the second step Western Blot and other clinical data and symptoms. This assay should not be used for general population screening. It should be used only for patients with signs and symptoms consistent with Lyme disease. Potential assay interference due to circulating antibodies against Human Ehrlichiosis,Tick Borne Relapsing Fever, Babesiosis, Parvovirus and EBV infections has been found.